Related references
Note: Only part of the references are listed.BCL2 Predicts Survival in Germinal Center B-cell-like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab
Javeed Iqbal et al.
CLINICAL CANCER RESEARCH (2011)
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Ryan D. Morin et al.
NATURE (2011)
SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors
Rodrigo Goya et al.
BIOINFORMATICS (2010)
Correlations between BCL6 rearrangement and outcome in patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP
Jesse Shustik et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin et al.
NATURE GENETICS (2010)
Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line: a need for an alternative BCL2 antibody
Noraidah Masir et al.
PATHOLOGY (2010)
Poor outcome in patients with diffuse large B-cell lymphoma is associated with high percentage of bcl-2 and Ki 67-positive tumor cells
Maja Perunicic-Jovanovic et al.
Vojnosanitetski Pregled (2010)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy
Kerry J. Savage et al.
BLOOD (2009)
BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma
Masumichi Saito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The biochemistry of somatic hypermutation
Jonathan U. Peled et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
A novel paradigm for rapid ABT-737-induced apoptosis involving outer mitochondrial membrane rupture in primary leukemia and lymphoma cells
M. Vogler et al.
CELL DEATH AND DIFFERENTIATION (2008)
JNK1-mediated phosphorylation of BcI-2 regulates starvation-induced autophagy
Yongjie Wei et al.
MOLECULAR CELL (2008)
Two levels of protection for the B cell genome during somatic hypermutation
Man Liu et al.
NATURE (2008)
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Ali Mortazavi et al.
NATURE METHODS (2008)
BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents
Jing Deng et al.
CANCER CELL (2007)
Bcl-2 and Ca2+ homeostasis in the endoplasmic reticulum
P. Pinton et al.
CELL DEATH AND DIFFERENTIATION (2006)
Bcl2's flexible loop domain regulates p53 binding and survival
Xingming Deng et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization
Y Tomita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma
J Iqbal et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Structural conservation of residues in BH1 and BH2 domains of Bcl-2 family proteins
GU Gurudutta et al.
FEBS LETTERS (2005)
Lack of Bcl-2 expression in follicular lymphoma may be caused by mutations in the BCL2 gene or by absence of the t(14;18) translocation
M Schraders et al.
JOURNAL OF PATHOLOGY (2005)
Variant t(14;18) in malignant lymphoma: a report of seven cases
G Bentley et al.
CANCER GENETICS AND CYTOGENETICS (2005)
Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3
BZ Lin et al.
CELL (2004)
Defining the p53 DNA-binding domain BcL-XL-binding interface using NMR
AM Petros et al.
FEBS LETTERS (2004)
Mono- and multisite phosphorylation enhances Bcl2's antiapoptotic function and inhibition of cell cycle entry functions
XM Deng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma
J Iqbal et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
CP Hans et al.
BLOOD (2004)
Bcl2 retards G1/S cell cycle transition by regulating intracellular ROS
XM Deng et al.
BLOOD (2003)
Rituximab plus CHOP (R-CHOP) overcomes bcl-2-associated resistance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL)
N Mounier et al.
BLOOD (2003)
Human non-synonymous SNPs: server and survey
V Ramensky et al.
NUCLEIC ACIDS RESEARCH (2002)
Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas
L Pasqualucci et al.
NATURE (2001)
Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18)
DE Horsman et al.
GENES CHROMOSOMES & CANCER (2001)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
Share Paper
